JP2019529346A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019529346A5 JP2019529346A5 JP2019502575A JP2019502575A JP2019529346A5 JP 2019529346 A5 JP2019529346 A5 JP 2019529346A5 JP 2019502575 A JP2019502575 A JP 2019502575A JP 2019502575 A JP2019502575 A JP 2019502575A JP 2019529346 A5 JP2019529346 A5 JP 2019529346A5
- Authority
- JP
- Japan
- Prior art keywords
- pylori
- hopq
- loop
- ceacam
- pylori hopq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16180430.7A EP3272354A1 (en) | 2016-07-20 | 2016-07-20 | Agents and methods for the prevention or treatment of h. pylori infections |
| EP16180430.7 | 2016-07-20 | ||
| PCT/EP2017/068297 WO2018015468A1 (en) | 2016-07-20 | 2017-07-20 | Agents and methods for the prevention or treatment of h. pylori infections |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019529346A JP2019529346A (ja) | 2019-10-17 |
| JP2019529346A5 true JP2019529346A5 (https=) | 2020-08-13 |
| JP7189124B2 JP7189124B2 (ja) | 2022-12-13 |
Family
ID=56511365
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019502575A Active JP7189124B2 (ja) | 2016-07-20 | 2017-07-20 | Ｈ．ピロリ感染の予防又は治療に関する作用物質及び方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US11471532B2 (https=) |
| EP (2) | EP3272354A1 (https=) |
| JP (1) | JP7189124B2 (https=) |
| CN (1) | CN109715188A (https=) |
| AU (1) | AU2017300021B2 (https=) |
| CA (1) | CA3030787A1 (https=) |
| MX (1) | MX2019000428A (https=) |
| WO (1) | WO2018015468A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3272354A1 (en) | 2016-07-20 | 2018-01-24 | Technische Universität München | Agents and methods for the prevention or treatment of h. pylori infections |
| US11150237B2 (en) | 2018-03-30 | 2021-10-19 | The Regents Of The University Of California | Patient-specific biomarkers of Escherichia coli invasion in inflammatory bowel disease |
| CN108794585A (zh) * | 2018-05-28 | 2018-11-13 | 广东工业大学 | 一种抗幽门螺杆菌的卵黄抗体制备方法及应用 |
| KR102370176B1 (ko) * | 2020-03-02 | 2022-03-03 | 한국생명공학연구원 | HopQ를 포함하는 암전이 억제용 조성물 |
| EP3909601A1 (en) * | 2020-05-11 | 2021-11-17 | LeukoCom GmbH | A novel antibody binding specifically to human ceacam1/3/5 and use thereof |
| CN111675750B (zh) * | 2020-06-11 | 2022-08-30 | 中国药科大学 | 针对癌胚抗原相关黏附分子ceacam的肿瘤靶向肽及其应用 |
| CN112322693A (zh) * | 2020-11-24 | 2021-02-05 | 上海健康医学院 | 一种巨噬细胞中幽门螺丝杆菌的标记方法 |
| CN113388616B (zh) * | 2021-07-27 | 2022-04-26 | 中国海洋大学 | 特异性结合幽门螺旋杆菌的核酸适配体、生物元件、生物传感器及检测方法 |
| CN118480136B (zh) * | 2024-06-19 | 2025-01-14 | 南京澄实生物医药科技有限公司 | 一种预防和治疗金黄色葡萄球菌感染的免疫原性组合物 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR003125A1 (es) | 1995-06-01 | 1998-07-08 | Astra Ab | Antigenos bacterianos para el diagnostico de infecciones con helicobacter pylori, una molecula de adn que lo codifica, un vector, una celula huesped,procedimiento para producir el polipeptido, composiciones para vacunas adecuadas para uso terapeutico y profilactico, el uso del polipeptido en la |
| US20050063987A1 (en) | 1996-07-26 | 2005-03-24 | Chiron Behring Gmbh & Co | Proteins, in particular membrane proteins, of Helicobacter pylori, their preparation and use |
| US20020151462A1 (en) | 1998-02-19 | 2002-10-17 | Ling Lissolo | Helicobacter pylori membrane proteins |
| SE9801287D0 (sv) | 1998-04-14 | 1998-04-14 | Astra Ab | Incorporation of active substances in carrier matrixes |
| SE9801288D0 (sv) | 1998-04-14 | 1998-04-14 | Astra Ab | Vaccine delivery system and metod of production |
| NZ509127A (en) * | 1998-06-19 | 2004-01-30 | Merieux Oravax | Use of LT (E. coli) and CT (cholera toxin) for inducing immune responses against helicobacter infection |
| WO2001083531A1 (en) | 2000-04-27 | 2001-11-08 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Method for identifying helicobacter antigens |
| GB0010371D0 (en) | 2000-04-29 | 2000-06-14 | Astrazeneca Ab | Helicobacter pylori antigens |
| EP1301204A1 (en) | 2000-07-05 | 2003-04-16 | Merieux OraVax SNC | Immunological combinations for prophylaxis and therapy of helicobacter pylori infection |
| DE10032538A1 (de) | 2000-07-05 | 2002-01-17 | Max Planck Gesellschaft | Vakzine gegen Helicobacter pylori |
| WO2002066501A2 (en) | 2001-01-02 | 2002-08-29 | Hybrigenics | PROTEIN-PROTEIN INTERACTIONS IN $i(HELICOBACTER PYLORI) |
| JP2005506322A (ja) | 2001-08-31 | 2005-03-03 | カイロン ソチエタ ア レスポンサビリタ リミタータ | Ｈｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉワクチン接種 |
| JP3823268B2 (ja) | 2002-05-30 | 2006-09-20 | 独立行政法人科学技術振興機構 | ヘリコバクター・ピロリの細胞死誘導剤 |
| EP1599164B1 (en) | 2003-02-03 | 2015-04-08 | Cerebus Biologicals, Inc. | Methods for treating, preventing and detecting helicobacter infection |
| EP1622933A2 (en) | 2003-04-22 | 2006-02-08 | Intercell AG | H. pylori antigens |
| US20070042448A1 (en) | 2005-06-02 | 2007-02-22 | Institute Pasteur | Use of enzymes from Helicobacter pylori as therapeutical targets |
| CN100460013C (zh) | 2006-09-05 | 2009-02-11 | 重庆康卫生物科技有限公司 | 口服重组幽门螺杆菌疫苗及其制备方法 |
| EP1913955A1 (en) | 2006-10-19 | 2008-04-23 | Gerhard, Markus | Novel method for treating H.pylori infections |
| SI22889A (sl) | 2008-10-28 | 2010-04-30 | Kemijski inštitut | Himerni flagelini za cepiva |
| WO2011018779A1 (en) | 2009-08-13 | 2011-02-17 | The Provost, Fellows and Scholars of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin | Modified helicobacter protein |
| WO2011081598A1 (en) | 2009-12-28 | 2011-07-07 | Mivac Development Aktiebolag | New antigens for use in a vaccine against h.pylori infection |
| CN101955545B (zh) | 2010-09-07 | 2012-07-04 | 四川万可泰生物技术有限责任公司 | 一种多靶点重组基因及其蛋白在防治幽门螺旋杆菌感染中的应用 |
| EP2844301A2 (en) | 2012-05-04 | 2015-03-11 | Ineb-instituto de Engenharia Biomédica | Microspheres for treating helicobacter pylori infections |
| EP3272354A1 (en) | 2016-07-20 | 2018-01-24 | Technische Universität München | Agents and methods for the prevention or treatment of h. pylori infections |
-
2016
- 2016-07-20 EP EP16180430.7A patent/EP3272354A1/en not_active Withdrawn
-
2017
- 2017-07-20 EP EP17749134.7A patent/EP3487517B1/en active Active
- 2017-07-20 WO PCT/EP2017/068297 patent/WO2018015468A1/en not_active Ceased
- 2017-07-20 CA CA3030787A patent/CA3030787A1/en active Pending
- 2017-07-20 JP JP2019502575A patent/JP7189124B2/ja active Active
- 2017-07-20 AU AU2017300021A patent/AU2017300021B2/en active Active
- 2017-07-20 MX MX2019000428A patent/MX2019000428A/es unknown
- 2017-07-20 US US16/317,753 patent/US11471532B2/en active Active
- 2017-07-20 CN CN201780045021.7A patent/CN109715188A/zh active Pending
-
2022
- 2022-09-21 US US17/934,113 patent/US12558425B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019529346A5 (https=) | ||
| JP2014527398A5 (https=) | ||
| JP2009001563A5 (https=) | ||
| MX2024003355A (es) | Anticuerpos anti-cd3. | |
| JP2015533788A5 (https=) | ||
| Wu et al. | The non-coding RNA llme23 drives the malignant property of human melanoma cells | |
| JP2018042573A5 (https=) | ||
| Terragni et al. | EGFR, HER-2 and KRAS in canine gastric epithelial tumors: a potential human model? | |
| JP2014528714A5 (https=) | ||
| JP2016026303A5 (https=) | ||
| JP2015516813A5 (https=) | ||
| JP2016519285A5 (https=) | ||
| JP2009539082A5 (https=) | ||
| PE20071055A1 (es) | Anticuerpos anti mn | |
| JP2012525432A5 (https=) | ||
| MX349996B (es) | Metodos y composiciones para diagnostico y tratamiento del cancer. | |
| Li et al. | Gastric cancer patients with Helicobacter pylori infection have a poor prognosis | |
| Falchetti et al. | Glioblastoma endothelium drives bevacizumab‐induced infiltrative growth via modulation of PLXDC1 | |
| RU2016144178A (ru) | Антитело против muc1 или его антигенсвязывающий фрагмент и его применение | |
| WO2017194499A1 (en) | Tissue-specific exosomes as biomarkers | |
| WO2006110589A3 (en) | Gammaretrovirus associated with cancer | |
| JP2019532633A5 (https=) | ||
| JPWO2021075545A5 (https=) | ||
| DK2054443T3 (da) | Antistoffer mod en epitop fra AGR2, assays og hybridomer | |
| UA108349C2 (uk) | Гуманізоване антитіло з протипухлинною активністю |